GNC deal with Chinese-owned Harbin Pharmaceuticals sparks national security concerns

Published September 4, 2020 3:39pm ET



The potential acquisition of supplement chain GNC by Chinese-owned Harbin Pharmaceuticals has sparked concerns in Congress and among allies of President Trump’s “America First” trade policy, who are calling for a national security review of the deal over claims it could grant Beijing-controlled Harbin access to U.S. military bases and service members’ sensitive information.

Florida Rep. Bill Posey and the Coalition for a Prosperous America, a group that backs domestic companies and supports the Trump administration’s trade efforts, detailed their concerns in letters to Treasury Secretary Steven Mnuchin on Thursday.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.